Browsing by Subject "R&D Productivity"
Now showing items 1-1 of 1
(uga, 2014-08)The pharmaceutical industry in the U.S. has changed since the introduction of the 1984 Hatch-Waxman Act. At first look, it seems generic firms are benefiting greatly from the Act, while brand firms are not. In this ...